Shares of German pharma major Bayer were up 4.6% at 30.45 euros after it released positive early trial results for its ...

Shionogi said today that it has submitted a New Drug Application (NDA) in Japan for zuranolone, a treatment in development ...

Repair Biotechnologies has partnered with Genevant Sciences to combine its Cholesterol Degrading Platform (CDP) mRNA ...

Lundbeck presented data from the TALISMAN study and AMULET trial of amlenetug for multiple system atrophy (MSA) at the ...

The US Food and Drug Administration yesterday approved pharma major Bristol Myers Squibb’s Cobenfy (xanomeline and trospium ...

Chicago, USA-based ARCH Venture Partners revealed it has closed the ARCH Venture Fund XIII, a venture capital fund with more ...

Enanta Pharmaceuticals announced positive topline results from a Phase IIa trial of EDP-323, its RSV replication inhibitor, ...

Sage Therapeutics announced that Biogen has ended its partnership on the SAGE-324 program after the drug failed in a Phase II ...

European Commission (EC) has issued a marketing authorization for FYB202/Otulfi, a biosimilar to Johnson & Johnson’s Stelara.

A US Food and Drug Administration advisory committee meeting has recommended restricting the use of PD-1 inhibitors, in a ...

USA-based biotech funder and incubator Flagship Pioneering yesterday unveiled Mirai Bio, a company pioneering the first open ...

AbbVie announced positive topline results from its Phase III TEMPO-1 trial for tavapadon as a monotherapy for early Parkinson ...